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Abstract 
Background and aims: Macrophages play important roles in adipose tissue inflammation and its consequences. 
Unfortunately, a detailed description of the macrophage phenotypes in different human adipose tissues is not 
available.
Subjects and methods: Subcutaneous, visceral and perivascular adipose tissues were obtained from 52 living 
kidney donors during live donor nephrectomy. Stromal vascular fractions were isolated, and the macrophage pheno-
types were analyzed by flow cytometry using surface markers (CD14, CD16, CD36, and CD163).
Results: In addition to CD16 positivity, pro-inflammatory macrophages also display high scavenger receptor CD36 
expression. The great majority of CD16 negative macrophages express the anti-inflammatory CD163 marker. The pres-
ence of pro-inflammatory macrophages was almost twice as high in visceral (p < 0.0001) and perivascular (p < 0.0001) 
adipose tissues than in subcutaneous tissue. This difference was substantially more pronounced in the postmenopau-
sal women subgroup, consequentlly, the total difference was driven by this subgroup.
Conclusion: We obtained detailed information about M1 and M2 macrophage phenotypes in human adipose 
tissue. The visceral and perivascular adipose tissues had substantially higher pro-inflammatory characteristics than 
the subcutaneous tissue. The higher proportion of pro-inflammatory macrophages in the visceral adipose tissue of 
postmenopausal women might be related to an increased cardiovascular risk.
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Background
Recently, interest in the field of adipose tissue biology has 
been increasing. The principal focus has been on subclin-
ical low-grade inflammation, which has been suggested 
to link obesity to its metabolic complications, especially 
insulin resistance and type 2 diabetes mellitus [1]. Adi-
pose tissue was considered a rather inert organ for many 
years and was viewed as an energy store that could be 
mobilized during periods of starvation. In the 1990s, this 
approach was completely revised following the discov-
ery of the massive endocrinal, paracrine, and autocrine 
potential of adipose tissue [2]. In addition to its role in 
energy metabolism, adipose tissue may impact both local 
and systemic metabolic processes during healthy and 
unhealthy periods [3].
Chemoattractive cytokines influence macrophage traf-
ficking. There is considerable evidence from animal and 
human experiments that obese adipose tissue is mark-
edly infiltrated by macrophages [4–7]. At the tissue level, 
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and phenotypic changes in adipose tissue macrophages 
(ATM); these cells appear to be at the center of obesity-
related inflammation [8]. Once recruited, the macrophages 
themselves secrete additional chemokines, which initi-
ate a feed-forward loop that potentiates the inflammatory 
response [9]. Macrophage infiltration and pro-inflamma-
tory gene expression in adipose tissue together with the 
increase in subclinical inflammatory markers precede the 
metabolic consequences [5]. Therefore, macrophages may 
be important players in the initiation of insulin resistance. 
Macrophage turnover in tissues is the result of several bio-
logical processes, including recruitment, local prolifera-
tion, apoptosis, and macrophage egress [10, 11].
Macrophage populations are highly heterogeneous, 
and several activation states of macrophages have been 
observed. This macrophage diversity has led to an effort to 
categorize the macrophage populations. The most preva-
lent approach is to define the M1 and M2 systems primar-
ily by macrophage properties in  vitro. M1 macrophages 
are generated by treating monocytes with lipopolysaccha-
ride or interferon-γ, whereas increasing concentrations 
of IL-4/IL-13 or IL-10 are inducers of M2 macrophages 
[12, 13]. Although these in  vitro studies are demonstra-
tive, an in  vivo analogy can only be hypothesized. M1 
macrophages are predominant in sites of inflammation 
and therefore are considered to be pro-inflammatory pri-
marily due to their high production of pro-inflammatory 
cytokines. Both the numbers and proportions of these 
two phenotypes might play important roles [8]. However, 
a strict definition of adequate M1 and M2 macrophage 
surface markers has not been clear to date.
Obesity is also associated with qualitative changes in 
ATM phenotypes and functions [14]. An animal model 
showed that external stimuli, such as physical activity 
or diet, could induce a switch in macrophage subpopu-
lations [15–17]. However, because macrophage mark-
ers differ between rodents and humans, it is difficult to 
extrapolate these results to human adipose tissue. Addi-
tionally, results from flow cytometry analyses of human 
adipose tissue [4, 18, 19] suggest that an individual ATM 
might simultaneously bear both M1 and M2 character-
istics [4]. Adipose tissues isolated from different depots 
demonstrate different features [20]. Thus, it seems prob-
able that the differences in non-adipose cell types may 
contribute to this finding. The aims of our study were as 
follows:
  • To determine the macrophage subpopulations in 
human adipose tissue.
  • To compare the proportions of the macrophage sub-
populations in the subcutaneous (SCAT), visceral 
(VAT), and perivascular (PVAT) tissues of healthy 
individuals.
  • To determine the possible relationship of the above-
mentioned data with age.
We utilized the recently enlarged transplantation pro-
gram of living kidney donors at our institute to obtain 
fresh, preoperatively isolated human adipose tissues.
Methods
Study participants
SCAT, VAT (outside of Gerota’s fascia), and PVAT (sur-
rounding the arteria renalis) were intra-operatively 
obtained from living kidney donors during hand-assisted 
retroperitoneoscopic live donor nephrectomy. Apart 
from the SCAT, the removal of VAT and PVAT is a stand-
ard procedure prior to transplantation.
Clinical data were collected from clinical documenta-
tion of the enrolled subjects and from an interview tar-
geting lifestyle factors. Prior to enrollment in the study, 
the subjects were thoroughly informed about the study 
and informed consent forms were signed. The study was 
approved by the local Ethics Committee.
Biochemistry
The total cholesterol, triglyceride and HDL cholesterol 
fractions were determined from fasting blood samples 
obtained immediately prior to the operation (prior to 
anesthesia) using an enzymatic method (Hoffmann-
LaRoche, Switzerland). The concentration of the HDL 
fraction was analyzed after the precipitation of apopro-
tein B-containing particles using a phosphotungstate 
method. hsCRP (high-sensitivity C-reactive protein) 
was measured using an immunoturbidimetric assay 
with an autoanalyzer (Cobas Mira Plus, Roche, Basel, 
Switzerland).
Stromal vascular fraction isolation
The stromal vascular fraction (SVF) was separated using 
a procedure modified according to Zuk [21]. Approxi-
mately 2-gram SCAT, VAT and PVAT samples (sur-
rounding the arteria renalis) were cleaned of connective 
tissue, blood vessels, and blood residue. The samples 
were minced with scissors (approximately 1  mm3) and 
exposed to collagenase (2  mg/ml, Sigma-Aldrich) in 
phosphate-buffered saline solution for 20  min at 37  °C. 
The digestate was immediately cooled and subsequently 
filtered using two filters (150 μm and then 50 μm). After 
repeated washing, the stromal vascular fraction was 
obtained.
Macrophage markers
Based on data from the literature [18, 20, 22–24] and 
our recent results [25], we suggest that macrophages 
with high phagocytic activity characterized by CD16 
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expression and high CD36 expression but no CD163 
expression should correspond to normally stimulated M1 
macrophages. Conversely, macrophages with no CD16 
expression but CD163 positivity might be considered 
anti-inflammatory M2 macrophages. We are aware that 
this classification could oversimplify the in vivo situation 
where the full phenotypic spectrum of transient pheno-
types between M1 and M2 may exist.
Flow cytometry analysis
Stromal vascular cells and blood samples from the 
subjects were incubated with a cocktail of monoclo-
nal antibodies conjugated with specific fluorochromes 
[CD14-phycoerythrin (PE)-cyanine 7, CD16-phyco-
erythrin-Texas Red-X, CD36-fluorescein isothiocyanate 
(FITC), and CD163-PE clone RM3/1] and the appropriate 
isotype controls (Beckman Coulter) for 30 min shielded 
from light. All of the antibodies were purchased from 
Beckman Coulter (Brea, CA, USA) except for CD163 
(BioLegend, CA, USA). The flow cytometry analysis was 
performed within 2 h of staining.
All flow cytometry analyses were performed on a CyAn 
ADP 9C flow cytometer using the Kaluza software (Beck-
man Coulter, Brea, CA, USA).
Due to difficulties in delineating CD16 positive cells in 
the SVF, the CD16 positive monocytes were first identi-
fied and delineated in a blood sample where the CD16 
positive subpopulation was clearly visible. The setting 
was fixed and subsequently used for the SVF analysis. 
The gating strategy used to identify the SVF macrophage 
subpopulations is shown in Fig. 1.
The proportion of ATM subpopulations was expressed 
as a percentage of all monocytes/macrophages. The abso-
lute number of macrophages per gram of adipose tis-
sue was determined by calculating the dilution and the 
amount of adipose tissue applied. Additionally, the pro-
portion of ATM subpopulations was expressed as a per-
centage of all macrophages. Due to technical difficulties, 
some samples were not analyzed for absolute numbers 
of monocytes (approximately 5  % of the adipose tissue 
samples).
The viability of the analyzed cells was measured for 
each sample using the 7-aminoactinomycin D (7-AAD) 
method. Only samples with viabilities higher than 75  % 
were considered.
Subpopulations representing less than 5 % were omit-
ted from the analysis.
Because the main fraction of blood monocytes (CD14+ 
CD16−163−) was not observed in the tested adipose tis-
sue samples, the confounding effect of blood contamina-
tion (despite thorough repeated washing of the samples) 
can be neglected.
Statistical analysis
The investigated subpopulations were normally dis-
tributed. Therefore, the significance of the differences 
between them was tested using the appropriate unpaired 
or paired Student’s t test method. All tests were two 
tailed, and the level of significance was set at 0.05. The 
statistical analyses and correlation were performed with 
the biostatistics software Prism, version 5 (GraphPad 
Prism).
Results
A total of 52 living kidney donors were identified (19 men 
and 33 women, out of whom 16 were premenopausal and 
17 were postmenopausal ages). However, eight subjects 
did not agree with SCAT removal and therefore only 44 
SCAT samples were analyzed. Our study group was gen-
erally healthier than a gender- and age-matched group 
selected from a large representative sample of the same 
population [13] and therefore could be regarded as rela-
tively healthy individuals. However, due to the recently 
more flexible criteria for living kidney donation, the 
prevalence of light hypertension was approximately 20 %, 
overweight was 36  %, obesity was 13 and 33  % of the 
subjects were smokers. The increased LDL concentra-
tion prevalence was 8 %, the decreased HDL concentra-
tion (lower than 1.0 mmol l−1 in men and 1.3 mmol l−1 in 
women) was 58  % and hypertriglyceridemia (more than 
1.6 mmol l−1) was present in 26 % of subjects.
No differences in age were found in the men compared 
to the women (45.09  ±  8.98 and 46.60  ±  11.53  years) 
(Table 1). The mean BMI of the men was 26.94 ± 3.74 kg/
m2 and the mean BMI of all women was 25.17 ± 3.48 kg/
m2 (p =  0.05); there was no difference in BMI between 
women with pre- and postmenopausal ages. The total 
cholesterol concentrations of the men did not differ from 
the women. Nevertheless, the older women had substan-
tially higher total cholesterol than the younger women 
(p  <  0.05). No differences in non-HDL cholesterol val-
ues were found in the men compared to the women, 
with higher non-HDL cholesterol concentration in the 
women of postmenopausal age than in the women of 
premenopausal age (p < 0.02). The male group displayed 
significantly lower HDL concentrations compared to all 
of the women (p  <  0.01); no differences were observed 
in the female subgroups. No differences were observed 
in the mean fasting triglyceride concentrations in men 
compared to women and between women with pre- and 
post-menopausal ages. There were no gender or age dif-
ferences in CRP between the groups.
The total number of macrophages per gram did 
not significantly differ between the SCAT, VAT 
and PVAT (10,900  ±  12,250, 13,200  ±  10,350 and 
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Fig. 1 Example of the SVF flow cytometric analysis. a CD16 positive monocytes were first identified and delineated in the blood sample (left, 
CD16positive macrophages in the upper part). The setting was fixed and subsequently used for the SVF analysis (b). Total macrophages in the SVF 
were identified by positivity for CD14 (c). Based on the CD16 marker, two subpopulations were distinguished (b, CD16-positive macrophages in 
the upper part). d The CD16+ subpopulation was divided according to CD36 marker markers (d, left) and then the CD163 presence was deter-
mined within both the CD36 positive subpopulations [i.e., CD16+ CD36high (d, middle) and CD16+ CD36low (d, right)]. Similarly, the CD16 negative 
subpopulation was divided according to the CD36 marker (e, left) and then the CD163 presence was determined in both the CD16− CD36low (e, 
middle) and CD16− CD36− subpopulations (e, right)
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15,650  ±  15,100  macrophages/g, respectively). When 
the SVF macrophages were divided according to CD16 
positivity, a lower proportion of CD16 positive mac-
rophages was found in the SCAT compared to the VAT 
(48.9 ± 14.3 vs. 53.4 ± 13.3 %; p < 0.02) (Table 2).
In all tissues, CD16+ macrophages were also CD36 
positive, and two subpopulations could be clearly dis-
tinguished (CD36low and CD36high). The proportion of 
CD16+ CD36high macrophages was higher in the VAT 
and PVAT (39.4  ±  13.4 and 38.7  ±  15.5) than in the 
SCAT (32.7 ± 13.7 %, p < 0.02 and p < 0.05, respectively); 
no difference was observed between the VAT and PVAT.
When these CD16+ CD36high macrophages were 
divided according to the presence of CD163, the SCAT 
macrophages were approximately evenly distributed 
(19.9  ±  9.5  % CD163+ and 14.3  ±  8.0  % CD163−), 
whereas the proportion of CD163+ macrophages 
accounted for only half of the CD163-negative mac-
rophages in the VAT (15.4 ± 6.8 and 25.5 ± 11.8 %) and 
PVAT (13.5 ± 8.1 and 29.2 ± 12.6 %). The only significant 
difference in the CD16+36high163+ subpopulation was 
between the SCAT and PVAT (p  <  0.005). Conversely, 
the differences between the SCAT and both the VAT 
and PVAT were highly significant when the CD16+36high 
CD163− subpopulation that corresponded to pro-
inflammatory M1 macrophages was analyzed (both 
p < 0.0001).
The CD16+36low macrophage prevalence was higher 
in the SCAT than in the PVAT (p < 0.01), but no other 
significant differences between the adipose tissues 
were observed. In this subpopulation, the majority of 
cells (~90  %) also expressed the CD163 surface marker. 
When the presence of the CD163 marker was included, 
the CD14+ CD16+36low163+ subpopulation was sig-
nificantly lower in both the visceral (p  <  0.05) and 
perivascular (p < 0.005) adipose tissues compared to the 
subcutaneous tissue.
In contrast to the CD16+ macrophages, macrophages 
lacking CD16 exhibited low CD36 expression. How-
ever, only a minor proportion of this subpopulation 
Table 1 Characteristics of the living kidney donor subgroups
Data are expressed as the mean of the proportion ±SD and by significance according to the Student’s unpaired parametric t test
W Women (n = 33), M men (n = 19), PreW premenopausal women (n = 16) and PostW postmenopausal women (n = 17), n.s. non-significant
Parameters Women (W) Men (M) Significance (M × W) PreW PostW Significance (PreW × PostW)
Age (years) 46.60 ± 11.53 45.09 ± 8.98 n.s. 43.22 ± 5.26 56.24 ± 5.48 p < 0.0001
BMI (kg m−2) 25.17 ± 3.48 26.94 ± 3.74 p = 0.05 24.42 ± 3.39 25.97 ± 3.49 n.s.
Total cholesterol (mmol l−1) 4.37 ± 1.01 4.32 ± 0.64 n.s. 4.01 ± 0.70 4.86 ± 1.20 p < 0.05
HDL-C (mmol l−1) 1.32 ± 0.35 0.99 ± 0.26 p < 0.01 1.32 ± 0.26 1.31 ± 0.47 n.s.
nonHDL-C (mmol l−1) 3.15 ± 1.07 3.39 ± 0.64 n.s. 2.69 ± 0.68 3.54 ± 0.99 p < 0.02
Triglycerides (mmol l−1) 1.23 ± 0.78 1.57 ± 0.64 n.s. 1.11 ± 0.42 1.39 ± 1.10 n.s.
hsCRP (mg l−1) 1.66 ± 2.90 1.18 ± 1.34 n.s. 1.61 ± 2.33 1.72 ± 3.67 n.s.
Table 2 Different phenotypes of macrophages isolated from adipose tissues
Proportions of macrophages isolated from subcutaneous (SCAT, n = 44), visceral (VAT, n = 52) and perivascular (PVAT, n = 52) adipose tissues, n.s. non-significant
Results are expressed as the mean of the proportion ±SD and by significance according to the Student’s paired parametric t test







+ % 48.9 ± 14.3 p < 0.02 53.4 ± 13.3 n.s. 50.6 ± 14.0 n.s.
+ +++ % 32.7 ± 13.7 p < 0.02 39.4 ± 13.4 n.s. 38.7 ± 15.5 p < 0.05
+ + % 14.1 ± 7.7 n.s. 12.4 ± 7.5 n.s. 10.4 ± 6.9 p < 0.01
+ +++ + % 19.9 ± 9.5 n.s. 15.4 ± 6.8 n.s. 13.5 ± 8.1 p < 0.005
+ +++ − % 14.3 ± 8.0 p < 0.0001 25.5 ± 11.8 p < 0.05 29.2 ± 12.6 p < 0.0001
+ + + % 13.1 ± 6.2 n.s. 11.8 ± 6.8 p < 0.05 9.4 ± 5.3 p < 0.005
− % 51.1 ± 14.3 p < 0.02 46.6 ± 13.3 n.s. 49.4 ± 14.0 n.s.
− + % 45.0 ± 13.5 p < 0.02 40.4 ± 12.1 n.s. 41.8 ± 12.3 n.s.
− − % 6.1 ± 5.0 n.s. 6.9 ± 6.3 n.s. 7.6 ± 7.2 n.s.
− + + % 43.9 ± 13.1 p < 0.02 39.0 ± 12.2 n.s. 39.7 ± 12.5 n.s.
− − + % 5.8 ± 4.9 n.s. 5.8 ± 6.2 n.s. 7.1 ± 6.9 n.s.
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(approximately 7 %) did not express the CD36 marker at 
all.
The majority of the CD16− CD36low macrophages were 
equivocally CD163− positive, as were the majority of the 
CD16− CD36− macrophages. Therefore, when all of the 
CD16− macrophages were evaluated together, 95 ± 4 % 
expressed the anti-inflammatory marker CD163. Conse-
quently, the proportions of CD16− CD36low and CD16− 
CD36low CD163+ macrophages were also higher in the 
SCAT compared to the VAT (p < 0.02).
In the whole group of living kidney donors, the propor-
tion of pro-inflammatory macrophages was lower in the 
SCAT compared to the VAT and PVAT. These differences 
increased when their phenotypes became gradually more 
specified from CD16+ to CD16+ CD36high and finally to 
CD16+36high CD163−.
Upon analyzing the data from a relatively large set of 
SVFs obtained from different adipose tissues, we found 
substantial differences between the subgroups of women 
with premenopausal (n  =  16) and postmenopausal 
(n = 17) ages (Table 3). No substantial differences were 
found when the males were compared with the entire 
group of women. Therefore, we compared selected ATM 
subpopulations according to their menopausal status. 
The cut-off point for the menopausal status was 51 years, 
and the menopausal status was verified using a follicle-
stimulating hormone measurement (FSH  >  29  IU/ml). 
Although no significant differences in the proportion of 
CD16+ subpopulations were found in the different adi-
pose tissues of women of premenopausal age (Table  3), 
a highly significant difference was found between the 
SCAT and VAT (p  <  0.005) in the subgroup of women 
of postmenopausal age in the presence of pro-inflam-
matory macrophages. Women of postmenopausal age 
also had a higher proportion of CD16+  macrophages 
in the VAT compared to women of premenopausal age 
(59.0 ± 12.0 % vs. 47.2 ± 15.1, p < 0.02).
Similarly, no differences in the presence of CD16+36high 
macrophages in the different adipose tissues were found 
in women of premenopausal age. The lower proportion 
of these subpopulations in the SCAT compared to the 
VAT and PVAT that was observed in the entire group 
evaluation increased in the women of postmenopausal 
age (p  <  0.0005 and p  <  0.001, respectively). Although 
the proportions of CD16+ CD36high macrophages were 
higher in the VAT and PVAT of women of postmenopau-
sal compared to premenopausal age, these differences 
reached significance (p < 0.05) only in the PVAT.
Upon analyzing the M1 macrophage subpopulations, 
it was evident that although the lower proportions of 
CD16+36high163− macrophages in the SCAT compared 
to the VAT and PVAT were significant in both female 
groups, these differences in the subgroup of postmeno-
pausal age women were very high (p  <  0.0005). Addi-
tionally, only women of postmenopausal age displayed 
a slightly lower proportion of CD16+36high163− mac-
rophages in the VAT compared to the PVAT (p < 0.05). 
Women of postmenopausal age had a higher proportion 
of CD16+36high163− macrophages in the VAT compared 
to women of premenopausal age (p < 0.05). However, no 
differences were found when the SCAT and PVAT were 
compared.
The women of postmenopausal age had a higher pro-
portion of anti-inflammatory CD16− CD36low CD163+ 
Table 3 Different phenotypes of macrophages isolated from adipose tissues from women
Proportions of macrophages isolated from subcutaneous adipose tissues of women of premenopausal age (SCAT, n = 15) and from visceral and perivascular adipose 
tissues (VAT and PVAT, n = 16) of women of postmenopausal age (SCAT, n = 16, VAT and PVAT, n = 17), n.s. non-significant
The results are expressed as the mean of the proportion ±SD and by significance according to the Student’s paired parametric t test and the * Student’s unpaired 
parametric t test







+ % PreW 47.8 ± 13.9 n.s. 47.2 ± 15.1 n.s. 48.1 ± 12.7 n.s.
PostW 47.8 ± 14.6 p < 0.005 59.0 ± 12.0 n.s. 55.7 ± 13.7 n.s.
P* (PreW × PostW) n.s. p < 0.02 n.s.
+ +++ % PreW 30.8 ± 13.4 n.s. 34.7 ± 16.0 n.s. 34.8 ± 13.0 n.s.
PostW 31.7 ± 14.7 p < 0.0005 42.8 ± 11.9 n.s. 45.2 ± 15.3 p < 0.001
P* (PreW × PostW) n.s. n.s. p < 0.05
+ +++ − % PreW 13.7 ± 8.9 p < 0.02 22.0 ± 6.3 n.s. 25.2 ± 12.5 p < 0.005
PostW 16.3 ± 8.8 p < 0.0005 28.0 ± 11.4 p < 0.05 32.3 ± 11.4 p < 0.0001
P* (PreW × PostW) n.s. p < 0.05 n.s.
− + + % PreW 44.5 ± 13.7 n.s. 43.5 ± 14.1 n.s. 40.7 ± 12.7 n.s.
PostW 45.0 ± 13.2 p < 0.05 33.8 ± 10.5 n.s. 36.3 ± 12.2 n.s.
P* (PreW × PostW) n.s. p < 0.05 n.s.
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subpopulations in the SCAT compared to the VAT 
(p < 0.05). However, these differences were not detected 
in women of premenopausal age. Women of postmeno-
pausal age also had a slightly lower proportion of these 
macrophages in the VAT (p < 0.05) compared to women 
of premenopausal age.
Discussion
Our most interesting findings were as follows:
We confirmed that human adipose tissues contained 
both CD16 positive and CD16 negative macrophages. 
We demonstrated that the proportions of these subpop-
ulations differed between the SCAT and VAT or PVAT. 
Our data also revealed that CD36 expression markedly 
differed between the CD16+ and CD16− macrophages. 
Although high CD36 expression (CD36high) was detected 
in the CD16+ macrophages, the CD16− macrophages 
did not exhibit CD36high positivity. Conversely, the 
CD16− macrophages were primarily CD36low and this 
phenotype was also uniformly CD163 positive.
The proportion of CD16+ CD36high CD163− mac-
rophages was doubled in the VAT and PVAT compared 
to the SCAT. It is tempting to speculate that this phe-
nomenon reflects the higher metabolic and pro-inflam-
matory activities of visceral adipose tissues compared to 
subcutaneous tissues as has been repeatedly shown [26].
Although increased ATMs in obese adipose tissue have 
been repeatedly described, few studies have included 
quantification per gram of adipose tissue. Our results of 
total macrophage numbers per g of adipose tissue are in 
agreement with published studies [18, 19].
Others have also studied CD16 marker positivity in 
human subcutaneous adipose tissues. Kovacikova [18] 
found a slightly higher proportion of CD16 positive mac-
rophages (approximately 60  %) compared to our data 
(Table  2), whereas other authors [4, 27] showed only a 
minor CD16 positive subpopulation in the same types of 
adipose tissue. Because no data on CD16 positive mac-
rophages in visceral adipose tissues have been published, 
we cannot compare our results with others. In our study, 
ATMs showed a clearly different pattern when divided 
according to their CD16 expression levels when the 
CD36 and CD163 receptors were followed (Table 2). This 
finding indicates that the CD16 marker is not sufficient to 
fully distinguish pro-inflammatory macrophage subpop-
ulations. A higher presence of CD16+ macrophages was 
found in the VAT compared to the SCAT (Table 2). This 
finding is compatible with the proposed higher impor-
tance of VAT in subclinical inflammation induction due 
to adipose tissue accumulation.
CD36 is one of the pattern recognition receptors and 
is expressed not only in monocytes/macrophages but 
also in adipocytes, platelets, and other cell types. CD36 
is upregulated during the late stages of monocyte dif-
ferentiation [28] and serves as a scavenger receptor that 
binds different ligands, including oxidized low-density 
lipoprotein, oxidized phospholipids, long chain acids, 
cell-derived microparticles, and apoptotic cells [29]. The 
interaction of CD36 with its ligands induces a monocyte 
influx into tissues and the secretion of pro-inflammatory 
cytokines [29]. CD36 is also a fatty acid translocase that 
is involved in fatty acid uptake and esterification in mac-
rophages; thus, CD36 is regarded as important in foam 
cell formation during the progression of atherosclerosis 
[30]. The expression of the CD36 receptor in tissues can 
be modified by diet [31]. A very recent study identified 
a strong correlation between CD36 expression on ATMs 
and metabolic dysfunction [24]. Our data reveal that its 
expression differs markedly between CD16+ and CD16− 
macrophages. In our study, CD16+ macrophages pos-
sessed both high (CD36high) and low (or CD36low) CD36 
expression, whereas CD16− macrophages were not ever 
CD36high positive and expressed a low level of CD36 
(CD36low). We hypothesize that the differences in CD36 
expression clearly confirm that we have applied an appro-
priate method to delineate the CD16+ and CD16− mac-
rophage subpopulations (Fig. 1).
The hemoglobin scavenger receptor CD163 is exclu-
sively expressed on monocytes/macrophages. Its expres-
sion in ATMs differs according to their location (omental 
vs. subcutaneous) [19, 20]. CD163 is an M2 marker of 
alternatively stimulated macrophages in in  vitro stud-
ies [32–34], and the CD163 phenotype has also shown 
to be more frequent in subcutaneous ATMs after weight 
loss in men [20]. Contrary to the pro-inflammatory mac-
rophages, CD163 expression is reported to suppress the 
immune mechanism through local interleukin-10 secre-
tion [35]. Additionally, recently published nomenclature 
guidelines categorize CD163 as a marker of anti-inflam-
matory M2 macrophages [12].
We demonstrated (Table  2) that all CD16− mac-
rophages were CD163 positive in all three types of adipose 
tissue. Therefore, we believe that the CD16− CD36low 
CD163+ population should correspond to anti-inflam-
matory non-classical macrophages. The situation with 
CD16+ macrophages is different because the great major-
ity of CD16+ CD36high macrophages in the VAT and 
PVAT do not express substantial levels of CD163. How-
ever, recent results have shown [24] that stimulation of 
macrophages in adipose tissue does not follow the classi-
cal activation pathway and that CD36 expression in mac-
rophages can increase under activation in a metabolically 
unhealthy environment (i.e., high glucose, insulin and 
palmitate concentrations). This environment leads to met-
abolic activation that is independent of the pro-inflamma-
tory pathways. Therefore, these macrophages should be 
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considered metabolically activated pro-inflammatory mac-
rophages. Although it is difficult to establish an additional 
value of the CD163 marker for the M1/M2 dichotomy, its 
role is plausible in connection with the above-mentioned 
data. In our view, the fact that a large majority (95 %) of 
CD16− macrophages were also CD163+ strongly sup-
ported their classification as M2 macrophages.
We also found co-expression of pro- and anti-inflam-
matory markers of ATMs (i.e., CD16+ CD36high CD163+ 
macrophages), which seemed to confirm the prevail-
ing opinion that changes in the local microenvironment 
in  situ might evoke varying mixtures of M1 and M2 
responses, resulting in overlaps and a broad spectrum 
between the M1 and M2 macrophage phenotypes [20, 36, 
37]. Interestingly, this phenotype was slightly higher in 
the SCAT compared to the other adipose tissues.
Our group of living kidney donors represents appar-
ently healthy individuals. Their BMIs, prevalence of 
hypertension, and dyslipoproteinemia were slightly 
lower compared to the last population survey of a repre-
sentative Czech population sample reported by the post-
MONICA WHO project of 2007 [38]. Additionally, the 
cholesterol and non-HDL cholesterol levels in our group 
were approximately 17 % lower than the general popula-
tion. Nevertheless, the exclusion criteria for living kidney 
donors have slightly shifted in our transplantation center 
similar to other centers, and three hypertonic individu-
als with dyslipoproteinemia and seven obese individuals 
were accepted into the program.
Based on the results shown in Tables 2 and 3, several 
points should be highlighted. First, the inclusion of two 
additional macrophage markers (CD36 and CD163) 
improves the M1 and M2 definition compared to the use 
of only one of these markers. Second, the VAT and PVAT 
display a higher pro-inflammatory M1 proportion than 
the SCAT, whereas the situation with M2 is obviously 
reversed. Third, there are no important differences in the 
ATM subpopulations when all females are compared to 
males, but significant differences are detectable between 
pre- and postmenopausal women. All pro-inflammatory 
parameters are increased upon the menopausal change; 
this shift highlights the importance of this period during 
cardiovascular risk changes.
The limitations of the present study are primarily the 
relatively low number of individuals included in the study 
and our strict definitions of the M1 and M2 subpopula-
tions, which were based on our interpretation of the avail-
able information from the literature and our own data.
Conclusions
Using a unique approach, we were able to identify mac-
rophage phenotypes present in human adipose tis-
sues and to compare subcutaneous with visceral and 
perivascular fat in identical subjects. Nevertheless, it is 
still too early to determine how the differences in mac-
rophage subpopulations reflect the physiological func-
tions of adipose tissues or how they affect interactions 
between adipose tissue cells.
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